Skip to main content

Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
multiple inhaler triple therapy (MITT)
single inhaler triple therapy (SITT)
Description

In this study, we assessed drug utilization patterns of single inhaler triple therapy (SITT) and multiple inhaler triple therapy (MITT) among a target population of triple therapy-naïve patients with chronic obstructive pulmonary disease (COPD) who had evidence of exacerbations despite dual therapy maintenance treatment in the Sentinel Distributed Database (SDD).

We distributed this request to five Sentinel Data Partners (DPs) on July 30, 2024. The study period included data from October 1, 2017 to January 1, 2024.

Deliverables (1)
Sentinel Modular Program Report: Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
October 1, 2017 - January 1, 2024
Analysis Type
Descriptive
Population / Cohort
Individuals aged 40 years and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis